Main > RHEUMATOLOGY > Ankylosing Spondylitis > Treatment. > Co.: CH. N. Brand SecukinuMAb

---

Co.: CH. N. Brand SecukinuMAb's subsections
(*) USA Approval Date: 2016. 01.15.
Company
Target: IL-17A
TradeMark
TradeMark Web-Site

Co.: CH. N. Brand SecukinuMAb's products
This section has no products